The latest closing stock price for Trevi Therapeutics as of January 21, 2025 is 3.56.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-549 today, roughly -1 times their original investment - a -12.44% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 4.68, which is 31.5% above the current share price.
The Trevi Therapeutics 52-week low stock price is 1.31, which is 63.2% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 2.95.
An investor who bought $1,000 worth of Trevi Therapeutics stock at the IPO in 2019 would have $-549 today, roughly -1 times their original investment - a -12.44% compound annual growth rate over 6 years.
The all-time high Trevi Therapeutics stock closing price was 10.12 on June 03, 2019.
The Trevi Therapeutics 52-week high stock price is 4.68, which is 31.5% above the current share price.
The Trevi Therapeutics 52-week low stock price is 1.31, which is 63.2% below the current share price.
The average Trevi Therapeutics stock price for the last 52 weeks is 2.95.